Ophthalmic drug delivery systems
Author(s)
Bibliographic Information
Ophthalmic drug delivery systems
(Drugs and the pharmaceutical sciences, v. 130)
M. Dekker, c2003
2nd ed., rev. and expanded
Available at 2 libraries
  Aomori
  Iwate
  Miyagi
  Akita
  Yamagata
  Fukushima
  Ibaraki
  Tochigi
  Gunma
  Saitama
  Chiba
  Tokyo
  Kanagawa
  Niigata
  Toyama
  Ishikawa
  Fukui
  Yamanashi
  Nagano
  Gifu
  Shizuoka
  Aichi
  Mie
  Shiga
  Kyoto
  Osaka
  Hyogo
  Nara
  Wakayama
  Tottori
  Shimane
  Okayama
  Hiroshima
  Yamaguchi
  Tokushima
  Kagawa
  Ehime
  Kochi
  Fukuoka
  Saga
  Nagasaki
  Kumamoto
  Oita
  Miyazaki
  Kagoshima
  Okinawa
  Korea
  China
  Thailand
  United Kingdom
  Germany
  Switzerland
  France
  Belgium
  Netherlands
  Sweden
  Norway
  United States of America
Note
Includes bibliographies and index
Description and Table of Contents
Description
The second edition of this text assembles significant ophthalmic advances and encompasses breakthroughs in gene therapy, ocular microdialysis, vitreous drug disposition modelling, and receptor/transporter targeted drug delivery.
Table of Contents
"I: Fundamental Considerations 1. Overview of Ocular Drug Delivery 2. Membrane Transport Processes in the Eye 3. General Considerations in Ocular Drug Delivery II: Transport Models in Ocular Drug Delivery 4. Ocular Drug Transfer following Systemic Drug Administration 5. Ocular Pharmacokinetics and Pharmacodynamics 6. Mathematical Modeling of Drug Distribution in the Vitreous Humor 7. Anterior Segment Microdialysis 8. Posterior Segment Microdialysis III: Drug Delivery Systems 9. Ocular Penetration Enhancers 10. Corneal Collagen Shields for Ocular Drug Delivery 11. The Noncorneal Route in Ocular Drug Delivery 12. Ocular Iontophoresis 13. Mucoadhesive Polymers in Ophthalmic Drug Delivery 14. Microparticles and Nanoparticles in Ocular Drug Delivery 15. Dendrimers: An Innovative and Enhanced Ocular Drug Delivery System 16. Ocular Delivery and Therapeutics of Proteins and Peptides 17. Retinal Disease Models for Development of Drug and Gene Therapies
18. New Experimental Therapeutic Approaches for Degenerative Diseases of the Retina 19. Gene, Oligonucleotide, and Ribozyme Therapy in the Eye IV: Regulatory Aspects 20. Regulatory Considerations 21. Patent Considerations"
by "Nielsen BookData"